OncLive | Bringing the Global Oncology Community Together

Asian patients with untreated ALK-positive advanced NSCLC lived significantly longer without disease progression if they received the next-generation tyrosine kinase inhibitor alectinib instead of crizotinib as initial... Read More >>

ESMO 2018: Neoadjuvant Nivolumab Plus Ipilimumab Active in dMMR Early-Stage Colon Cancer

ESMO 2018: Frontline Atezolizumab Plus Carboplatin/Nab-Paclitaxel Improves OS in Nonsquamous NSCLC

ESMO 2018: Cisplatin Remains Standard for Low-Risk HPV+ Oropharyngeal Cancer

More Research Required to Advance Pediatric Ph-Like ALL Paradigm

ESMO 2018: Long-Term Data Sustain Dabrafenib/Trametinib RFS Benefit in BRAF+ Melanoma

View More Stories >>

View Conference Coverage

2018 State of the Science Summit on Hematologic Malignancies in Clayton

State of the Science Summit on GI Cancers in Newport Beach

2018 ESMO Congress

2018 State of the Science Summit on Hematologic Malignancies in Cleveland

2018 Lynn Sage Breast Cancer Symposium

Dr. Grigg on Frontline Tyrosine Kinase Inhibitors in RCC

Dr. Burgess on the Synergy Between Abiraterone and ADT in Prostate Cancer

Dr. Iqbal on Second- and Third-Line Therapies in Gastric Cancer

Dr. Burtness on Findings of KEYNOTE-048 in Head and Neck Cancer

Dr. Parker on the Role of Radiotherapy in Newly Diagnosed Prostate Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Take-Home Messages on the NSCLC Treatment Paradigm

Other Targeted Approaches in NSCLC: NTRK or RET Fusions

Considering Targeted Agents in BRAF-Mutant NSCLC

Sequencing Therapies in ALK-Rearranged NSCLC

Changing the Treatment Paradigm for ALK-Rearranged NSCLC

Global Perspectives on Use of Osimertinib in EGFR+ NSCLC

Osimertinib's Role in EGFR+ Metastatic Lung Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Current State of Molecular Testing for Metastatic CRC

Future Management of Metastatic Colorectal Cancer

Emerging Therapy in Metastatic Colorectal Cancer

BEACON Trial: Triplet Therapy in BRAF V600E

Moving the AML Treatment Landscape Forward

Optimizing the Use of FLT3 Inhibitor Therapy for AML

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>